Akums Drugs and Pharmaceuticals Limited(IN:AKUMS)
₹769.80+4.45 (+0.58%)
IN:AKUMS
Akums Drugs and Pharmaceuticals Limited Revenue
₹769.80
At close:+4.45 (+0.58%)
Want to see IN:AKUMS full AI Analyst Report?
Akums Drugs and Pharmaceuticals Limited (AKUMS) Revenue
4 Followers
Akums Drugs and Pharmaceuticals Limited Revenue
Akums Drugs and Pharmaceuticals Limited had a revenue of 10.18B in the quarter ending Sep 30, 2024, with 0.90%. This bring the company's revenue in the last twelve months to 20.26B, Increased 100.90%. In the fiscal year ending Mar 31, 2025, Akums Drugs and Pharmaceuticals Limited had annual revenue of 43.59B with 7.07% growth.
- Revenue (ttm)
- 20.26B
- Revenue Growth
- 17.50%
- P/S Ratio
- 2.76
- Revenue/Employee
- INR 5,941,144
- Employees
- 7,337
- Market Cap
- INR 120.46B
Revenue Chart
Akums Drugs and Pharmaceuticals Limited Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 43.59B | 2.88B | 7.07% |
| Mar 31, 2025 | 40.71B | 514.11M | 1.28% |
| Mar 31, 2024 | 40.20B | 5.45B | 15.68% |
| Mar 31, 2023 | 34.75B | -1.72B | -4.72% |
| Mar 31, 2022 | 36.47B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company | Revenue |
|---|---|
| IN:AKUMS | 20.26B |
| IN:ALIVUS | 11.90B |
| IN:JUBLPHARMA | 86.08B |
| IN:SHILPAMED | 16.82B |
| IN:STAR | 48.59B |
| IN:SUDEEPPHRM | ― |